{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:03:36Z","timestamp":1761519816296,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-colorectal-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Colorectal Cancer"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.3816\/ccc.2007.n.013","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:06:24Z","timestamp":1221080784000},"page":"436-441","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mitomycin-C\/5-Fluorouracil\/Leucovorin and Hyperfractionated Radiation Therapy for Rectal Carcinoma: A Phase II Study with Long-Term Follow-up"],"prefix":"10.3816","volume":"6","author":[{"given":"Chadi","family":"Nabhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avanthi","family":"Ragam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Milton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leela","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur","family":"Hooberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Hartsell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andi","family":"Anthony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob D.","family":"Bitran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CCC.2007.n.013_bib1","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/jama.1990.03450110090034","article-title":"NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer","volume":"264","year":"1990","journal-title":"JAMA"},{"key":"10.3816\/CCC.2007.n.013_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1200\/JCO.1992.10.1.79","article-title":"Enhancement of radiation-induced downstaging of rectal cancer by fluorouracil and highdose leucovorin chemotherapy","volume":"10","author":"Minsky","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archsurg.137.2.206","article-title":"Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer","volume":"137","author":"Wichmann","year":"2002","journal-title":"Arch Surg"},{"key":"10.3816\/CCC.2007.n.013_bib4","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2007.n.013_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000078259","article-title":"Neoadjuvant radiochemotherapy in rectal cancer: for which patients and tumor stages?","volume":"38","author":"Rodel","year":"2004","journal-title":"Front Radiat Ther Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib6","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM200108303450910","article-title":"Refining multimodal therapy for rectal cancer","volume":"345","author":"Nelson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2007.n.013_bib7","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.1997.15.5.2040","volume":"15","author":"Bartelink","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib8","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1200\/JCO.1996.14.9.2527","article-title":"Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study","volume":"14","author":"Flam","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.3816\/CCC.2007.n.013_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1056\/NEJM198611133152014","article-title":"Survival after postoperative combination treatment of rectal cancer","volume":"315","author":"Douglass","year":"1986","journal-title":"N Engl J Med"},{"key":"10.3816\/CCC.2007.n.013_bib11","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1200\/JCO.2005.03.6095","article-title":"Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group trial 0012","volume":"24","author":"Mohiuddin","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0360-3016(00)00692-1","article-title":"Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: a phase II dose escalation study","volume":"48","author":"Chan","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib13","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1072-7515(98)00135-5","article-title":"Combined preoperative radiation and mitomycin\/5-fluorouracil treatment for locally advanced rectal adenocarcinoma","volume":"187","author":"Burke","year":"1998","journal-title":"J Am Coll Surg"},{"key":"10.3816\/CCC.2007.n.013_bib14","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archsurg.1996.01430170060012","article-title":"Preoperative \u201cchemoradiation\u201d for stages II and III rectal carcinoma","volume":"131","author":"Stryker","year":"1996","journal-title":"Arch Surg"},{"key":"10.3816\/CCC.2007.n.013_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0360-3016(00)00732-X","article-title":"Prognostic significance of postchemoradiation stage following preoperative chemotherapy and radiation for advanced\/recurrent rectal cancers","volume":"48","author":"Mohiuddin","year":"2000","journal-title":"Int J Radiat Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0360-3016(95)00020-Y","article-title":"Preoperative infusional chemoradiation therapy for stage T3 rectal cancer","volume":"32","author":"Rich","year":"1995","journal-title":"Int J Radiat Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0360-3016(02)02856-0","article-title":"Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer","volume":"54","author":"Kim","year":"2002","journal-title":"Int J Radiat Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib18","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1200\/JCO.2003.10.045","article-title":"Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial","volume":"21","author":"Gerard","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib19","first-page":"82","article-title":"Preoperative chemoradiation in rectal cancer: correlation of tumor response with survival","volume":"24","author":"Shivnani","year":"2004","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib20","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.ijrobp.2004.08.018","article-title":"Preoperative chemoradiation with oral tegafur within a multidisciplinary therapeutic approach in patients with T3-4 rectal cancer","volume":"61","author":"Diaz-Gonzalez","year":"2005","journal-title":"Int J Radiat Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.ejso.2005.12.002","article-title":"Pre-operative combined modality therapy in the management of locally advanced rectal cancer","volume":"32","author":"Ceelen","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib22","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1200\/JCO.2005.04.4875","article-title":"Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poorrisk rectal cancer","volume":"24","author":"Chau","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib23","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1200\/JCO.2004.08.170","article-title":"Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the Lyon R96-02 randomized trial","volume":"22","author":"Gerard","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib24","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1200\/JCO.2005.05.0963","article-title":"What is the best way to predict disease-free survival after preoperative radiochemotherapy for rectal cancer patients: tumor regression grading, nodal status, or circumferential resection margin invasion?","volume":"24","author":"Machiels","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib25","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijrobp.2005.08.009","article-title":"The radiation-induced changes in rectal mucosa: hyperfractionated vs. hypofractionated preoperative radiation for rectal cancer","volume":"64","author":"Starzewski","year":"2006","journal-title":"Int J Radiat Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib26","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/annonc\/mdi212","article-title":"A phase I-II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer","volume":"16","author":"Aschele","year":"2005","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/annonc\/mdj031","article-title":"A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancer","volume":"17","author":"Glynne-Jones","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CCC.2007.n.013_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JCO.1998.16.1.301","article-title":"Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer","volume":"16","author":"Meta-analysis Group in Cancer","year":"1998","journal-title":"J Clin Oncol"}],"container-title":["Clinical Colorectal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811704832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1533002811704832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T23:01:08Z","timestamp":1761519668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1533002811704832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S1533002811704832"],"URL":"https:\/\/doi.org\/10.3816\/ccc.2007.n.013","relation":{},"ISSN":["1533-0028"],"issn-type":[{"type":"print","value":"1533-0028"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitomycin-C\/5-Fluorouracil\/Leucovorin and Hyperfractionated Radiation Therapy for Rectal Carcinoma: A Phase II Study with Long-Term Follow-up","name":"articletitle","label":"Article Title"},{"value":"Clinical Colorectal Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CCC.2007.n.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}